NAC and mindfulness therapy for depression in youth
Treatments studied
Part of Mental health clinical trials.
This study tests whether a supplement called N-acetylcysteine (NAC) combined with a type of therapy called Mindfulness-Based Cognitive Therapy (MBCT) can help improve depression in teenagers and young adults. It looks at how these treatments affect brain chemicals and may reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 24 years old.
- You have mild depression (not moderate or severe).
- You are not currently taking any antidepressant or mood medication, or you have been off them for a long enough time.
- You have not had serious suicidal thoughts or attempts in the past 3 months.
- You have never been diagnosed with bipolar disorder, schizophrenia, or a psychotic disorder.
- You have not participated in a mindfulness-based therapy before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supplement called N-acetylcysteine (NAC) can help children aged 6-12 who have intense emotions and mood swings. It also looks at brain activity before and after treatment to see if NAC might improve emotional control.
This study tests a mindfulness-based program combined with “brain scan feedback” (fMRI neurofeedback) to see if it can help teenagers and young adults with major depression. It may help by teaching skills and tracking brain activity changes during treatment.
This study tests a new type of brain stimulation called accelerated intermittent theta burst stimulation (aiTBS) in young people (ages 13-20) with depression who have not tried many treatments before. The goal is to see if this treatment can safely help reduce depression symptoms.
This trial tests if a gentle electrical brain stimulation called tACS can help teens with depression who are already on stable medication. The treatment is added to their usual medication to see if it improves mood.
This study tests whether a structured, coordinated care pathway helps teens (and their caregivers) manage depression better than usual care. It aims to see if targeted treatment and follow-up improve depression symptoms over time.
This trial studies a non-drug brain stimulation technique (called tACS) that uses gentle electrical currents to help regulate mood in teenagers with first-episode depression who have not yet taken antidepressants. If effective, it could offer a drug-free option for managing depression.
Hear when a new Mild Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.